BR9508521A - Inibição da biossintese de leucotrienos com derivados de uréia - Google Patents

Inibição da biossintese de leucotrienos com derivados de uréia

Info

Publication number
BR9508521A
BR9508521A BR9508521A BR9508521A BR9508521A BR 9508521 A BR9508521 A BR 9508521A BR 9508521 A BR9508521 A BR 9508521A BR 9508521 A BR9508521 A BR 9508521A BR 9508521 A BR9508521 A BR 9508521A
Authority
BR
Brazil
Prior art keywords
leukotriene biosynthesis
inhibition
urea derivatives
compound
pharmaceutical composition
Prior art date
Application number
BR9508521A
Other languages
English (en)
Inventor
Stephen L Crooks
Bryon A Merrill
Paul D Wightman
Original Assignee
Minnesota Mining & Mfg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/455,643 external-priority patent/US5612377A/en
Application filed by Minnesota Mining & Mfg filed Critical Minnesota Mining & Mfg
Publication of BR9508521A publication Critical patent/BR9508521A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/17Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
BR9508521A 1994-08-04 1995-07-14 Inibição da biossintese de leucotrienos com derivados de uréia BR9508521A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28601794A 1994-08-04 1994-08-04
US08/455,643 US5612377A (en) 1994-08-04 1995-05-31 Method of inhibiting leukotriene biosynthesis
PCT/US1995/007667 WO1996003983A1 (en) 1994-08-04 1995-07-14 Inhibition of leukotriene biosynthesis with urea derivatives

Publications (1)

Publication Number Publication Date
BR9508521A true BR9508521A (pt) 1997-10-28

Family

ID=26963530

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9508521A BR9508521A (pt) 1994-08-04 1995-07-14 Inibição da biossintese de leucotrienos com derivados de uréia

Country Status (19)

Country Link
EP (1) EP0777471B1 (pt)
JP (1) JPH10503771A (pt)
AT (1) ATE228359T1 (pt)
AU (1) AU685980B2 (pt)
BR (1) BR9508521A (pt)
CA (1) CA2196701A1 (pt)
CZ (1) CZ287034B6 (pt)
DE (1) DE69528984T2 (pt)
DK (1) DK0777471T3 (pt)
ES (1) ES2185708T3 (pt)
FI (1) FI970452A0 (pt)
HU (1) HUT76830A (pt)
IL (1) IL114646A (pt)
NO (1) NO315786B1 (pt)
NZ (1) NZ290236A (pt)
PL (1) PL180668B1 (pt)
PT (1) PT777471E (pt)
SK (1) SK282777B6 (pt)
WO (1) WO1996003983A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6126919A (en) 1997-02-07 2000-10-03 3M Innovative Properties Company Biocompatible compounds for pharmaceutical drug delivery systems
FR2880022B1 (fr) * 2004-12-24 2007-08-24 Mayoly Spindler Soc Par Action Nouveaux derives de la n-hydroxy-n'-phenyluree et de la n-hydroxy-n'-phenylthiouree et leur utilisation comme inhibiteurs de la synthese de la melanine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5066658A (en) * 1988-11-10 1991-11-19 Ortho Pharmaceutical Corporation Substituted hydroxyureas
CA2046872A1 (en) * 1989-02-01 1990-08-02 Dee W. Brooks Lipoxygenase inhibiting compounds
JP2528741B2 (ja) * 1991-01-09 1996-08-28 ファイザー製薬株式会社 オキサゾ―ル、チアゾ―ルおよびイミダゾ―ル化合物

Also Published As

Publication number Publication date
WO1996003983A1 (en) 1996-02-15
DK0777471T3 (da) 2003-03-17
ATE228359T1 (de) 2002-12-15
NO970477L (no) 1997-03-14
PL180668B1 (pl) 2001-03-30
CZ287034B6 (en) 2000-08-16
NZ290236A (en) 1998-12-23
SK11097A3 (en) 1997-09-10
CZ31297A3 (en) 1997-09-17
MX9700860A (es) 1997-10-31
IL114646A (en) 2000-02-29
HUT76830A (en) 1997-11-28
FI970452A (fi) 1997-02-03
NO970477D0 (no) 1997-02-03
CA2196701A1 (en) 1996-02-15
NO315786B1 (no) 2003-10-27
JPH10503771A (ja) 1998-04-07
PL318539A1 (en) 1997-06-23
PT777471E (pt) 2003-04-30
AU3091795A (en) 1996-03-04
DE69528984T2 (de) 2003-09-04
EP0777471B1 (en) 2002-11-27
FI970452A0 (fi) 1997-02-03
AU685980B2 (en) 1998-01-29
SK282777B6 (sk) 2002-12-03
DE69528984D1 (de) 2003-01-09
IL114646A0 (en) 1995-11-27
ES2185708T3 (es) 2003-05-01
EP0777471A1 (en) 1997-06-11

Similar Documents

Publication Publication Date Title
IL136044A (en) 2-aminoacetamide derivatives and pharmaceutical compositions containing the same
ES2160949T3 (es) Derivados de fenilen-sulfonamida sustituidos en meta.
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
GEP20012388B (en) Metalloproteinase Inhibitors, Pharmaceutical Compositions on Their Base, Use and Methods for Obtaining and Intermediates
YU11997A (sh) Laktamski derivati i njihove farmaceutske kompozicije
CA2216796A1 (en) Quinazoline derivatives
BG103947A (en) Derivatives of 9-oxymerythromycin
DK0889875T3 (da) Cycloproylalkansyrederivater
GEP20032953B (en) Antitumor Agents
MX9708452A (es) Inhibidores de sialidasa bacteriana y metodos para fabricar y usar la misma.
KR960703863A (ko) 암 치료용 신규 비스-나프탈이미드(New Bis-naphthalimides for the Treatment of Cancer)
AU5390900A (en) Potassium channel blocking agents
BR9508521A (pt) Inibição da biossintese de leucotrienos com derivados de uréia
WO1995022544A3 (de) Substituierte 1,3,8-triaza-spiro(4,5)-decan-4-on-derivate als vorstufen zur herstellung von pharmazeutika

Legal Events

Date Code Title Description
FB36 Technical and formal requirements: requirement - article 36 of industrial property law
FA8 Dismissal: dismissal - article 36, par. 1 of industrial property law